STipe Therapeutics appoints Dr Natalie Sacks as Independent Board Member and Dr Richard Bethell as Chief Development Officer
16th April 2020
Portfolio
This post references, or is about STipe Therapeutics. Find out more by clicking below
Print Article
Email Article
Save Article
Stay Updated
Add your email below to stay updated with useful and informative content from Arix and our portfolio companies
